Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer
Affiliations: Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China, Department of Breast Surgery, The People's Hospital of Deyang, Deyang, Sichuan 618000, P.R. China, Key Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, P.R. China
- Published online on: February 14, 2020 https://doi.org/10.3892/ijo.2020.4987
- Pages: 932-944
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.